The customer obtained discordant, falsely elevated follicular stimulating hormone (fsh) results on one patient sample upon initial and repeat testing on an immulite 2000 xpi instrument, when using reagent lot 326.The discordant results were reported to the physician(s), who questioned them.The sample was repeated on two alternate platforms, resulting lower each time and matching the clinical picture of the patient.The corrected result obtained on the 2nd alternate platform was reported to the physician(s).There are no known reports of patient intervention or adverse health consequence due to the discordant, falsely elevated fsh result.
|